Biorestorative Therapies Inc (BRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,837 | 1,714 | 6,573 | 17,934 | 19,323 |
| Marketable Securities | 10,538 | 13,036 | 9,914 | N/A | N/A |
| Receivables | 16 | 16 | 45 | 16 | 16 |
| TOTAL | $12,783 | $15,129 | $16,888 | $18,324 | $19,879 |
| Non-Current Assets | |||||
| PPE Net | 304 | 261 | 231 | 267 | 140 |
| Intangibles | 781 | 803 | 530 | 551 | 571 |
| Other Non-Current Assets | 213 | 242 | 271 | 300 | 329 |
| TOTAL | $1,298 | $1,306 | $1,032 | $1,117 | $1,040 |
| Total Assets | $14,081 | $16,435 | $17,920 | $19,442 | $20,919 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 93 | 171 | 469 | 378 | 214 |
| Accrued Expenses | 233 | 130 | 115 | 115 | 156 |
| TOTAL | $470 | $440 | $717 | $622 | $494 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 124 | 162 | 199 | 234 | 268 |
| TOTAL | $124 | $162 | $199 | $234 | $268 |
| Total Liabilities | $594 | $603 | $916 | $856 | $762 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,888 | 3,768 | 3,674 | 3,646 | 3,637 |
| Retained earnings | -158,325 | -152,641 | -148,293 | -143,638 | -138,962 |
| Other shareholders' equity | 15 | 15 | 15 | 15 | 15 |
| TOTAL | $13,487 | $15,832 | $17,004 | $18,586 | $20,157 |
| Total Liabilities And Equity | $14,081 | $16,435 | $17,920 | $19,441 | $20,919 |